About Matt Rightmire

This author has not yet filled in any details.
So far Matt Rightmire has created 76 blog entries.

Evox Therapeutics completes £35 million Series B financing

Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading exosome therapeutics company, today announces that it has raised £35.5 million ($45.4 million) of new capital in a Series B financing round. Redmile Group led the financing with significant new investments from GV (formerly Google Ventures) and Cowen Healthcare Investments, alongside investments from Panacea Healthcare Venture, [...]

By |2018-09-04T10:12:02-04:00September 3rd, 2018|Dartmouth Innovation, News|

Compass Therapeutics Completes $132 Million Series A Financing to Advance Next-generation Antibody-based Therapeutics into the Clinic

Compass Therapeutics, a biotechnology company committed to the ambitious goal of comprehensively drugging the human immune system, today announced the closing of the final $49 million of its $132 million Series A financing. This financing will enable the company to advance its next-generation antibody-based therapeutics into the clinic. The financing was led by OrbiMed Advisors [...]

By |2018-07-12T11:02:15-04:00July 12th, 2018|Dartmouth Innovation, New Hampshire, News|

Autodesk acquires Assemble Systems to build up its construction tech vertical

Autodesk has made a name for itself among designers, engineers and architects with its 3D and other modelling software. Now, as it continues to build out its business in adjacent business areas like construction, it has acquired Assemble Systems, a startup that has built a platform to help plan and run building projects — and [...]

By |2018-07-10T13:31:02-04:00July 9th, 2018|Design & Engineering Software, News|

Peptide Display Company Orbit Discovery Closes £6.9M Series A Financing

Orbit Discovery Ltd, an Oxford, UK-based biotech company developing an industry-leading peptide identification and optimisation platform, today announced the closing of a £6.9M Series A Financing. The round was led by Oxford Sciences Innovation who were joined by new investors RT Ventures, Borealis Ventures, Perivoli Innovations, along with further investment from all existing investors and [...]

By |2018-09-04T10:10:31-04:00May 23rd, 2018|Dartmouth Innovation, News|

Vets First Choice To Merge With Henry Schein Animal Health

Henry Schein, Inc. (Nasdaq: HSIC) and Vets First Choice announced plans today for Henry Schein to spin off its Animal Health business and merge it with Vets First Choice, creating an innovative approach to advancing the delivery of animal health care designed to provide unique benefits to veterinarians, manufacturers, pet owners, and their pets. The [...]

By |2018-04-23T07:54:55-04:00April 23rd, 2018|News|

Adimab Announces Antibody Discovery Collaboration with Boehringer Ingelheim

Adimab, LLC, the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, today announced a multi-target partnership with Boehringer Ingelheim (BI). Under the terms of the agreement, Adimab will use its proprietary platform to discover and optimize antibodies against targets chosen by BI, who will have the rights to develop [...]

By |2018-01-10T09:38:57-04:00January 10th, 2018|Dartmouth Innovation|

Adimab Provides Year-End Update on 2017 Partnership Activities

Adimab, LLC, the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, today announced that in 2017 it entered into agreements with seven new companies. In addition, Adimab announced the expansion of 12 of its current partnerships and the achievement of 49 technical and development milestones across multiple collaborations. Read [...]

By |2018-01-10T09:40:13-04:00January 8th, 2018|Dartmouth Innovation, New Hampshire, News|

Paul Allen’s Vulcan backs ex-Amazon manager’s modular housing startup Blokable in $4.8M round

Investors are taking note of Blokable, a Seattle startup founded by a former Amazon manager that aims to cut costs for builders and residents alike through the construction of tech-powered manufactured housing. The company’s single- and multifamily housing will be made of modular units ranging in length from 18 feet to 38 feet that can [...]

By |2017-09-19T13:08:48-04:00September 15th, 2017|Design & Engineering Software, News|

Vets First Choice Announces Two Strategic Acquisitions in Specialty Pharmacy Market

Vets First Choice, the leading provider of technology enabled healthcare solutions for veterinary practices, announced today that its parent company, Direct Vet Marketing, has acquired Roadrunner Pharmacy and Atlas Pharmaceuticals. The acquisitions are part of a global initiative to professionalize prescription management services for veterinary practices. Roadrunner Pharmacy is the leading specialty compounding pharmacy, and [...]

By |2017-08-11T14:55:57-04:00August 10th, 2017|News|

Vets First Choice Raises $223 million to Fuel Expansion

Vets First Choice, the leading provider of technology enabled healthcare services for veterinary medicine, announced a $223 million strategic investment to accelerate growth, launch new innovative services, and begin a global expansion effort into Europe and Asia. Clayton, Dubilier & Rice and Hillhouse Capital Group led the investment, with participation from Viking Global Investors, Wellington [...]

By |2019-05-28T15:37:06-04:00July 19th, 2017|News|